SDGR

SEC source: 0001209191-20-007907 · doc4.xml · derivative · entry 7

SHAW DAVID E · CIK 0001023870 · 10% owner

Schrodinger Equity Holdings, LLC · CIK 0001801739 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by D. E. Shaw Valence Portfolios, L.L.C.

Disclosed balance after: 0

Underlying: Common Stock, $0.01 par value per share · 467,889 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.exercise_date: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.expiration_date: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · ownership.nature: D. E. Shaw & Co., L.P. is the investment adviser of D. E. Shaw Valence Portfolios, L.L.C. Additionally, David E. Shaw is President and sole shareholder of D. E. Shaw & Co. II, Inc., which is the managing member of D. E. Shaw & Co., L.L.C., which is the manager of D. E. Shaw Valence Portfolios, L.L.C. David E. Shaw disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any.

SEC source: 0001209191-20-007907 · doc4.xml · derivative · entry 6

SHAW DAVID E · CIK 0001023870 · 10% owner

Schrodinger Equity Holdings, LLC · CIK 0001801739 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by D. E. Shaw & Co., L.P.

Disclosed balance after: 0

Underlying: Common Stock, $0.01 par value per share · 1,133,158 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.exercise_date: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.expiration_date: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · ownership.nature: David E. Shaw is President and sole shareholder of D. E. Shaw & Co., Inc., which is the general partner of D. E. Shaw & Co., L.P. David E. Shaw disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any.

SEC source: 0001209191-20-007907 · doc4.xml · derivative · entry 5

SHAW DAVID E · CIK 0001023870 · 10% owner

Schrodinger Equity Holdings, LLC · CIK 0001801739 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Schrodinger Equity Holdings, LLC

Disclosed balance after: 0

Underlying: Common Stock, $0.01 par value per share · 14,890,845 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.exercise_date: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.expiration_date: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F2 · ownership.nature: Schrodinger Equity Holdings, LLC, which holds these securities, is owned in its entirety through a trust of which David E. Shaw is the trustee and beneficiary.

SEC source: 0001209191-20-007907 · doc4.xml · nonDerivative · entry 4

SHAW DAVID E · CIK 0001023870 · 10% owner

Schrodinger Equity Holdings, LLC · CIK 0001801739 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by D. E. Shaw Technology Development, LLC.

Disclosed balance after: 4,264

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F5 · ownership.nature: David E. Shaw is President and sole shareholder of D. E. Shaw & Co. II, Inc., which is the sole member of D. E. Shaw Technology Development, LLC.

SEC source: 0001209191-20-007907 · doc4.xml · nonDerivative · entry 3

SHAW DAVID E · CIK 0001023870 · 10% owner

Schrodinger Equity Holdings, LLC · CIK 0001801739 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by D. E. Shaw Valence Portfolios, L.L.C.

Disclosed balance after: 467,889

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F4 · ownership.nature: D. E. Shaw & Co., L.P. is the investment adviser of D. E. Shaw Valence Portfolios, L.L.C. Additionally, David E. Shaw is President and sole shareholder of D. E. Shaw & Co. II, Inc., which is the managing member of D. E. Shaw & Co., L.L.C., which is the manager of D. E. Shaw Valence Portfolios, L.L.C. David E. Shaw disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any.

SEC source: 0001209191-20-007907 · doc4.xml · nonDerivative · entry 2

SHAW DAVID E · CIK 0001023870 · 10% owner

Schrodinger Equity Holdings, LLC · CIK 0001801739 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by D. E. Shaw & Co., L.P.

Disclosed balance after: 1,133,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F3 · ownership.nature: David E. Shaw is President and sole shareholder of D. E. Shaw & Co., Inc., which is the general partner of D. E. Shaw & Co., L.P. David E. Shaw disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any.

SEC source: 0001209191-20-007907 · doc4.xml · nonDerivative · entry 1

SHAW DAVID E · CIK 0001023870 · 10% owner

Schrodinger Equity Holdings, LLC · CIK 0001801739 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Schrodinger Equity Holdings, LLC

Disclosed balance after: 14,890,845

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 10, 2020, all shares of Schrodinger, Inc. ("Issuer") Series A Preferred Stock, par value $0.01 per share, converted into shares of Issuer Common Stock, par value $0.01 per share, upon the closing of the Issuer's initial public offering of Common Stock without payment of consideration. The conversion rate was one share of Issuer Common Stock per each 7.47534 shares of Series A Preferred Stock. The Series A Preferred Stock was convertible into shares of Issuer Common Stock at any time and automatically upon the closing of the Issuer's initial public offering and had no expiration date.

F2 · ownership.nature: Schrodinger Equity Holdings, LLC, which holds these securities, is owned in its entirety through a trust of which David E. Shaw is the trustee and beneficiary.

SEC source: 0000899243-20-003796 · doc4.xml · derivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,641

Underlying: Common Stock · 93,641 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0000899243-20-003792 · doc4.xml · derivative · entry 1

Lebowitz Joel · CIK 0001797829 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,496

Underlying: Common Stock · 49,496 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0000899243-20-003808 · doc4.xml · derivative · entry 1

Brauner Shane · CIK 0001797721 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,509

Underlying: Common Stock · 53,509 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0000899243-20-003801 · doc4.xml · derivative · entry 1

WRIGHT TIMOTHY MICHAEL · CIK 0001686178 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,909

Underlying: Common Stock · 12,909 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest in full on February 5, 2021.

SEC source: 0000899243-20-003819 · doc4.xml · derivative · entry 1

Abel Robert Lorne · CIK 0001798179 · EVP, Science

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,773

Underlying: Common Stock · 133,773 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0000899243-20-003814 · doc4.xml · derivative · entry 1

Kapeller-Libermann Rosana · CIK 0001797835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,909

Underlying: Common Stock · 12,909 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest in full on February 5, 2021.

SEC source: 0000899243-20-003809 · doc4.xml · derivative · entry 1

Lynton Michael · CIK 0001606115 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,909

Underlying: Common Stock · 12,909 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest in full on February 5, 2021.

SEC source: 0000899243-20-003804 · doc4.xml · derivative · entry 1

Tran Yvonne · CIK 0001797777 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,659

Underlying: Common Stock · 200,659 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0000899243-20-003800 · doc4.xml · derivative · entry 1

Daniel Jennifer · CIK 0001797725 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,131

Underlying: Common Stock · 40,131 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0000899243-20-003798 · doc4.xml · derivative · entry 1

Farid Ramy · CIK 0001797707 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 896,280

Underlying: Common Stock · 896,280 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0000899243-20-003797 · doc4.xml · derivative · entry 1

Herman Jenny · CIK 0001797785 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,754

Underlying: Common Stock · 26,754 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0000899243-20-003795 · doc4.xml · derivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,909

Underlying: Common Stock · 12,909 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest in full on February 5, 2021.

SEC source: 0000899243-20-003793 · doc4.xml · derivative · entry 1

D'Cruz Cony · CIK 0001797727 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,443

Underlying: Common Stock · 33,443 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0000899243-20-003794 · doc4.xml · derivative · entry 2

Friesner Richard · CIK 0001798426 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 535,092

Underlying: Common Stock · 535,092 shares

Expires 2030-02-04

F2 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0000899243-20-003794 · doc4.xml · derivative · entry 1

Friesner Richard · CIK 0001798426 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,909

Underlying: Common Stock · 12,909 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest in full on February 5, 2021.

SEC source: 0000899243-20-003791 · doc4.xml · derivative · entry 1

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,909

Underlying: Common Stock · 12,909 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest in full on February 5, 2021.

SEC source: 0000899243-20-003790 · doc4.xml · derivative · entry 1

Akinsanya Karen · CIK 0001797672 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,659

Underlying: Common Stock · 200,659 shares

Expires 2030-02-04

F1 · derivative.exercise_date: The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0001104659-20-019486 · a4.xml · derivative · entry 7

BILL & MELINDA GATES FOUNDATION TRUST · CIK 0001166559 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,164,193

Underlying: Common stock · 13,164,193 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: All shares of the Issuer's limited common stock have no expiration date and may be exchanged at the Trust's election into the Issuer's common stock on a 1-for-1 basis without payment of further consideration.

F5 · price: All shares of the Issuer's limited common stock have no expiration date and may be exchanged at the Trust's election into the Issuer's common stock on a 1-for-1 basis without payment of further consideration.

F5 · derivative.exercise_date: All shares of the Issuer's limited common stock have no expiration date and may be exchanged at the Trust's election into the Issuer's common stock on a 1-for-1 basis without payment of further consideration.

F5 · derivative.expiration_date: All shares of the Issuer's limited common stock have no expiration date and may be exchanged at the Trust's election into the Issuer's common stock on a 1-for-1 basis without payment of further consideration.

SEC source: 0001104659-20-019486 · a4.xml · derivative · entry 6

BILL & MELINDA GATES FOUNDATION TRUST · CIK 0001166559 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 4,487,226 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon closing of the Issuer's initial public offering ("IPO"), all of the Series E preferred stock held by Bill & Melinda Gates Foundation Trust (the "Trust") converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series E preferred stock.

F1 · price: Upon closing of the Issuer's initial public offering ("IPO"), all of the Series E preferred stock held by Bill & Melinda Gates Foundation Trust (the "Trust") converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series E preferred stock.

F1 · derivative.exercise_date: Upon closing of the Issuer's initial public offering ("IPO"), all of the Series E preferred stock held by Bill & Melinda Gates Foundation Trust (the "Trust") converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series E preferred stock.

F1 · derivative.expiration_date: Upon closing of the Issuer's initial public offering ("IPO"), all of the Series E preferred stock held by Bill & Melinda Gates Foundation Trust (the "Trust") converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series E preferred stock.

SEC source: 0001104659-20-019486 · a4.xml · derivative · entry 5

BILL & MELINDA GATES FOUNDATION TRUST · CIK 0001166559 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 4,808,612 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Upon closing of the Issuer's IPO, (i) 14,249,523 shares of Series D preferred stock converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration and (ii) 21,696,487 shares of Seried D preferred stock were voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis without further consideration. There was no expiration date for the Series D preferred stock.

F4 · price: Upon closing of the Issuer's IPO, (i) 14,249,523 shares of Series D preferred stock converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration and (ii) 21,696,487 shares of Seried D preferred stock were voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis without further consideration. There was no expiration date for the Series D preferred stock.

F4 · derivative.exercise_date: Upon closing of the Issuer's IPO, (i) 14,249,523 shares of Series D preferred stock converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration and (ii) 21,696,487 shares of Seried D preferred stock were voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis without further consideration. There was no expiration date for the Series D preferred stock.

F4 · derivative.expiration_date: Upon closing of the Issuer's IPO, (i) 14,249,523 shares of Series D preferred stock converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration and (ii) 21,696,487 shares of Seried D preferred stock were voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis without further consideration. There was no expiration date for the Series D preferred stock.

SEC source: 0001104659-20-019486 · a4.xml · derivative · entry 4

BILL & MELINDA GATES FOUNDATION TRUST · CIK 0001166559 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 6,319,743 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Upon closing of the Issuer's IPO, the Trust voluntarily exchanged all of its Series B preferred stock and Series C preferred stock into the Issuer's limited common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series B preferred stock or Series C preferred stock.

F3 · price: Upon closing of the Issuer's IPO, the Trust voluntarily exchanged all of its Series B preferred stock and Series C preferred stock into the Issuer's limited common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series B preferred stock or Series C preferred stock.

F3 · derivative.exercise_date: Upon closing of the Issuer's IPO, the Trust voluntarily exchanged all of its Series B preferred stock and Series C preferred stock into the Issuer's limited common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series B preferred stock or Series C preferred stock.

F3 · derivative.expiration_date: Upon closing of the Issuer's IPO, the Trust voluntarily exchanged all of its Series B preferred stock and Series C preferred stock into the Issuer's limited common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series B preferred stock or Series C preferred stock.

SEC source: 0001104659-20-019486 · a4.xml · derivative · entry 3

BILL & MELINDA GATES FOUNDATION TRUST · CIK 0001166559 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 3,942,041 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Upon closing of the Issuer's IPO, the Trust voluntarily exchanged all of its Series B preferred stock and Series C preferred stock into the Issuer's limited common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series B preferred stock or Series C preferred stock.

F3 · price: Upon closing of the Issuer's IPO, the Trust voluntarily exchanged all of its Series B preferred stock and Series C preferred stock into the Issuer's limited common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series B preferred stock or Series C preferred stock.

F3 · derivative.exercise_date: Upon closing of the Issuer's IPO, the Trust voluntarily exchanged all of its Series B preferred stock and Series C preferred stock into the Issuer's limited common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series B preferred stock or Series C preferred stock.

F3 · derivative.expiration_date: Upon closing of the Issuer's IPO, the Trust voluntarily exchanged all of its Series B preferred stock and Series C preferred stock into the Issuer's limited common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series B preferred stock or Series C preferred stock.

SEC source: 0001104659-20-019486 · a4.xml · nonDerivative · entry 2

BILL & MELINDA GATES FOUNDATION TRUST · CIK 0001166559 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,981,664

F2 · price: Represents shares acquired pursuant to an Issuer directed allocation in connection with the Issuer's IPO of common stock.

SEC source: 0001104659-20-019486 · a4.xml · nonDerivative · entry 1

BILL & MELINDA GATES FOUNDATION TRUST · CIK 0001166559 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,393,429

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon closing of the Issuer's initial public offering ("IPO"), all of the Series E preferred stock held by Bill & Melinda Gates Foundation Trust (the "Trust") converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration. There was no expiration date for the Series E preferred stock.

F4 · price: Upon closing of the Issuer's IPO, (i) 14,249,523 shares of Series D preferred stock converted automatically into the Issuer's common stock on a 7.47534-for-1 basis without payment of further consideration and (ii) 21,696,487 shares of Seried D preferred stock were voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis without further consideration. There was no expiration date for the Series D preferred stock.